Selected Cancer Drugs Recording Price Cuts Under NPPA’s TMR Revision, November 2026 Drug Manufacturer/Brand Focus area Old MRP (₹) Revised MRP (₹) Approx. price cut Bevacizumab 100 mg Zydus Lifesciences– Bryxta Lung, colon, ovarian & cervical cancer 25,995 3,318 87.2% Bevacizumab 100 mg Reliance Life Sciences– BevaciRel Lung, colon, ovarian & cervical cancer 24,079 3,985 83.4% Bevacizumab 100 mg Hetero Healthcare– CIZUMAB Lung, colon, ovarian & cervical cancer 15,658 3,103 80.2% Denosumab 60 mg Reliance Life Sciences– DenOsteoRel Breast & prostate cancerBbone loss 24,955 6,240 75.0% Pemetrexed 500 mg Reliance Life Sciences– ReliTrexed Lung cancer 9,977 1,113 88.8% Pemetrexed 500 mg Medicamen Biotech– PEMETOMED Lung cancer 5,062 940 81.4% Pertuzumab 420 mg Lupin– LUPIHER 2 Breast cancer 83,520 37,358 55.3% Azacitidine 100 mg Dr. Reddy’s Laboratories–Azacytin Blood cancers/Myelodysplastic syndromes 6,337 1,495 76.4% Dasatinib 20 mg Natco Pharma–Dasanat 20 Leukemia 2,812.50 1,085.93 61.4% Denosumab 60 mg RPG Life Sciences– Debrumab Breast & prostate cancer/Bone loss 22,031.25 5,941 73.0% Enzalutamide 40 mg RPG Life Sciences– Enuta Prostate cancer 6,578.20 2,232 66.1% Erlotinib 150 mg Neon Laboratories– ERLIB Lung cancer 4,637.45 2,008 56.7% Fludarabine 50 mg Hetero Healthcare– FLUDANOX Blood cancers 14,235 2,432 82.9% Fulvestrant 50 mg RPG Life Sciences– Fulbreca Breast cancer 26,072.16 5,491 78.9% Anastrozole 1 mg RPG Life Sciences– ANARZOLE Breast cancer 695.76 73 89.5% Pegfilgrastim 6 mg Hetero Healthcare– PEG FILTERO Prevention of chemotherapy-induced neutropenia 9,093 1,631 82.1% Abiraterone acetate 250 mg Arvincare Pharma– ABIRONE Prostate cancer 41,250 3,218.23 92.2% The government itself highlighted examples such as Bryxta (bevacizumab) falling from ₹25,995 to ₹3,318, ReliTrexed (pemetrexed) from ₹9,977 to ₹1,113 and LUPIHER 2 (pertuzumab) from ₹83,520 to ₹37,358. Press Information Bureau The earlier NPPA release also lists anastrozole, azacitidine, dasatinib, denosumab, enzalutamide, erlotinib, fludarabine and fulvestrant among the revised brands. Share this article